Shan-chun Wang

Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs.

Zhi-Hong Liu, Xiquan Zhang, Ling Yang, 2020, European journal of pharmacology.

The mechanism of ferroptosis regulating oxidative stress in ischemic stroke and the regulation mechanism of natural pharmacological active components.

Liuting Zeng, Kailin Yang, Jinwen Ge, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Magnesium isoglycyrrhizinate blocks fructose‐induced hepatic NF‐&kgr;B/NLRP3 inflammasome activation and lipid metabolism disorder

Shui-juan Wang, L. Kong, Ying Pan, 2017, European journal of pharmacology.

Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.

Xiquan Zhang, L. Kong, Tu-Shuai Li, 2019, Biochemical pharmacology.

Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling

Qiang Xu, Shui-juan Wang, L. Kong, 2018, Acta Pharmacologica Sinica.

Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling

Qiang Xu, Shui-juan Wang, L. Kong, 2018, Acta Pharmacologica Sinica.